Elizabeth Gregerson

Urine-based test detects prostate cancer with 91% accuracy: Johns Hopkins

09/03/2025

A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine.  Led by a team from Baltimore-based Johns Hopkins Kimmel Cancer Center and St. Petersburg, Fla.-based Johns Hopkins All Children’s Hospital, researchers developed…

Repurposed drugs successfully target cancer ‘sleeper cells’: 5 study notes

09/03/2025

Researchers have successfully used repurposed cancer drugs to target dormant breast cancer cells, aiding in the delay or prevention of recurrence, according to a study published Sept. 2 in Nature Medicine.  Researchers from Philadelphia-based University of Pennsylvania’s Abramson Cancer Center and Perelman School of Medicine enrolled 51 breast cancer survivors…

Why chaplains are an ‘untapped resource’ in healthcare

09/02/2025

Healthcare chaplains, also known as spiritual care providers, can play a key role in advancing hospitals’ and health systems’ strategic priorities. These professionals typically support organizations in three areas: workforce well-being, patient experience and access to care. Jason Lesandrini, PhD, assistant vice president of ethics, advance care planning, spiritual health…

‘Business as usual’ won’t to retain nurses: Massachusetts hospital CNO says

09/02/2025

In May, Holyoke (Mass.) Medical Center became one of 10 hospitals selected in Massachusetts to participate in an initiative, dubbed the Healthy Work Environment Academy, that aims to empower frontline nurses to lead workplace culture and retention efforts. “Nurses are sort of leaving the profession, and the ones at the…

Trump demands COVID ‘drug’ data from pharmaceutical companies

09/02/2025

President Donald Trump demanded that pharmaceutical companies release data for “success rates” of their COVID-19 medications to clear up what he called a “discrepancy mess.”  In a Sept. 1 Truth Social post, President Trump said he had been shown “extraordinary” results from Pfizer and other pharmaceutical companies that had not…

GLP-1s reduce heart failure death, hospitalization: 3 things to know

09/02/2025

Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA.  Researchers from Somerville, Mass.-based Mass General Brigham analyzed U.S. insurance claim data to emulate two previous semaglutide and tirzepatide trials at…

Mayo Clinic AI model predicts ALS

09/02/2025

Rochester, Minn.-based Mayo Clinic researchers have developed an artificial intelligence model that can predict amyotrophic lateral sclerosis and anticipate patient survival using data from F-wave nerve conduction studies. The model was trained on F-wave responses from 46,802 patients, including 5,329 with motor neuron disease in the training set, according to…